Works matching IS 00099236 AND DT 2017 AND VI 101 AND IP 4

Results: 20

Corrigendum: Adaptive biomedical innovation: Evolving our global system to sustainably and safely bring new medicines to patients in need.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 4, p. 542, doi. 10.1002/cpt.643
By:
- Hirsch, G;
- Trusheim, M;
- Cobbs, E;
- Bala, M;
- Garner, S;
- Hartman, D;
- Isaacs, K;
- Lumpkin, M;
- Lim, R;
- Oye, K;
- Pezalla, E;
- Saltonstall, P;
- Selker, H
Publication type:
Article
Validation of a microdose probe drug cocktail for clinical drug interaction assessments for drug transporters and CYP3A.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 4, p. 519, doi. 10.1002/cpt.525
By:
- Prueksaritanont, T;
- Tatosian, DA;
- Chu, X;
- Railkar, R;
- Evers, R;
- Chavez‐Eng, C;
- Lutz, R;
- Zeng, W;
- Yabut, J;
- Chan, GH;
- Cai, X;
- Latham, AH;
- Hehman, J;
- Stypinski, D;
- Brejda, J;
- Zhou, C;
- Thornton, B;
- Bateman, KP;
- Fraser, I;
- Stoch, SA
Publication type:
Article
Genetic advances uncover mechanisms of chemotherapy-induced peripheral neuropathy.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 4, p. 450, doi. 10.1002/cpt.590
By:
- Chua, KC;
- Kroetz, DL
Publication type:
Article
Issue Information.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 4, p. 421, doi. 10.1002/cpt.474
Publication type:
Article
Circulating acetaminophen metabolites are toxicokinetic biomarkers of acute liver injury.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 4, p. 531, doi. 10.1002/cpt.541
By:
- Vliegenthart, ADB;
- Kimmitt, RA;
- Seymour, JH;
- Homer, NZ;
- Clarke, JI;
- Eddleston, M;
- Gray, A;
- Wood, DM;
- Dargan, PI;
- Cooper, JG;
- Antoine, DJ;
- Webb, DJ;
- Lewis, SC;
- Bateman, DN;
- Dear, JW
Publication type:
Article
Therapeutic disasters that hastened safety testing of new drugs.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 4, p. 430, doi. 10.1002/cpt.613
By:
- Paine, MF
Publication type:
Article
Cardio-Oncology: Progress in Diagnosis and Treatment of Cardiac Dysfunction.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 4, p. 481, doi. 10.1002/cpt.614
By:
- Tromp, J;
- Steggink, LC;
- Van Veldhuisen, DJ;
- Gietema, JA;
- van der Meer, P
Publication type:
Article
Systems pharmacology modeling of drug-induced hyperbilirubinemia: Differentiating hepatotoxicity and inhibition of enzymes/transporters.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 4, p. 501, doi. 10.1002/cpt.619
By:
- Yang, K;
- Battista, C;
- Woodhead, JL;
- Stahl, SH;
- Mettetal, JT;
- Watkins, PB;
- Siler, SQ;
- Howell, BA
Publication type:
Article
Structure of proof of concept studies that precede a nonalcoholic steatohepatitis development program.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 4, p. 444, doi. 10.1002/cpt.560
By:
- Williams, RN;
- Filozof, C;
- Goldstein, BJ;
- Cusi, K
Publication type:
Article
Drug-induced liver injury: Advances in mechanistic understanding that will inform risk management.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 4, p. 469, doi. 10.1002/cpt.564
By:
- Mosedale, M;
- Watkins, PB
Publication type:
Article
3D bioengineered tissues: From advancements in in vitro safety to new horizons in disease modeling.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 4, p. 453, doi. 10.1002/cpt.569
By:
- Hardwick, RN;
- Viergever, C;
- Chen, AE;
- Nguyen, DG
Publication type:
Article
Aberrant mTOR signaling and disrupted autophagy: The missing link in potential vigabatrin-associated ocular toxicity?
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 4, p. 458, doi. 10.1002/cpt.581
By:
- Vogel, KR;
- Ainslie, GR;
- Pearl, PL;
- Gibson, KM
Publication type:
Article
Predicting transporter-mediated drug interactions: Commentary on: 'Pharmacokinetic evaluation of a drug transporter cocktail consisting of digoxin, furosemide, metformin and rosuvastatin' and 'Validation of a microdose probe drug cocktail for clinical drug interaction assessments for drug transporters and CYP3A'
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 4, p. 447, doi. 10.1002/cpt.588
By:
- Zhang, L;
- Sparreboom, A
Publication type:
Article
Drug-induced ototoxicity: Mechanisms, Pharmacogenetics, and protective strategies.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 4, p. 491, doi. 10.1002/cpt.603
By:
- Lanvers‐Kaminsky, C;
- Zehnhoff‐Dinnesen, AG am;
- Parfitt, R;
- Ciarimboli, G
Publication type:
Article
Profiling of Kidney Injury Biomarkers in Patients Receiving Cisplatin: Time-dependent Changes in the Absence of Clinical Nephrotoxicity.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 4, p. 510, doi. 10.1002/cpt.606
By:
- George, B;
- Wen, X;
- Mercke, N;
- Gomez, M;
- O'Bryant, C;
- Bowles, DW;
- Hu, Y;
- Hogan, SL;
- Joy, MS;
- Aleksunes, LM
Publication type:
Article
Effect of everolimus on the pharmacokinetics of octreotide long-acting repeatable in patients with advanced neuroendocrine tumors: An analysis of the randomized phase III RADIANT-2 trial.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 4, p. 462, doi. 10.1002/cpt.559
By:
- Pavel, ME;
- Becerra, C;
- Grosch, K;
- Cheung, W;
- Hasskarl, J;
- Yao, JC
Publication type:
Article
In This Issue.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 4, p. 429, doi. 10.1002/cpt.625
Publication type:
Article
Highlights.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 4, p. 435, doi. 10.1002/cpt.626
Publication type:
Article
Corrigendum: The effect of an abuse-deterrent opioid formulation (OxyContin) on opioid abuse-related outcomes in the postmarketing setting.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 4, p. 541, doi. 10.1002/cpt.627
Publication type:
Article
ASCPT News.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 4, p. 437, doi. 10.1002/cpt.624
Publication type:
Article